(0.03%) 5 470.97 points
(0.08%) 39 143 points
(0.34%) 17 779 points
(-0.01%) $80.82
(-3.66%) $2.66
(-0.80%) $2 312.10
(0.18%) $28.92
(3.49%) $1 020.80
(0.24%) $0.935
(0.66%) $10.67
(0.42%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs...
Stats | |
---|---|
今日成交量 | 87 910 |
平均成交量 | 84 624 |
市值 | 352.67M |
EPS | $-0.380 ( Q2 | 2024-04-30 ) |
Last Dividend | $0.130 ( 2015-02-02 ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.126 (1.58%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-30 | Bryce Richard Paul | Buy | 153 000 | Stock Option (Right to Buy) |
2023-11-30 | Daws D. Ryan | Buy | 232 000 | Stock Option (Right to Buy) |
2023-11-27 | Daws D. Ryan | Buy | 0 | |
2023-10-31 | Forbion Capital Fund Iii Cooperatief U.a. | Sell | 0 | Class A common shares |
2023-11-30 | Forbion Capital Fund Iii Cooperatief U.a. | Sell | 475 076 | Warrant (Right to Buy) |
INSIDER POWER |
---|
-38.61 |
Last 15 transactions |
Buy: 475 436 | Sell: 921 648 |
音量 相关性
enGene Holdings Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
enGene Holdings Inc. 相关性 - 货币/商品
enGene Holdings Inc. 财务报表
Annual | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
enGene Holdings Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.180 | 2012-04-02 |
Last Dividend | $0.130 | 2015-02-02 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $2.52 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
Unable to generate commentary due to missing data.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
02 Feb 2015 | $0.130 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
01 Dec 2014 | $0.140 | 01 Dec 2014 | 30 Nov -0001 | 05 Dec 2014 |
03 Nov 2014 | $0.150 | 03 Nov 2014 | 30 Nov -0001 | 07 Nov 2014 |
01 Oct 2014 | $0.150 | 01 Oct 2014 | 30 Nov -0001 | 07 Oct 2014 |
01 May 2014 | $0.130 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
02 Dec 2013 | $0.120 | 29 Nov 2013 | 30 Nov -0001 | 06 Dec 2013 |
01 Nov 2013 | $0.120 | 01 Nov 2013 | 30 Nov -0001 | 07 Nov 2013 |
01 Oct 2013 | $0.120 | 01 Oct 2013 | 30 Nov -0001 | 07 Oct 2013 |
01 Aug 2013 | $0.120 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
01 May 2013 | $0.120 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
26 Dec 2012 | $0.110 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
03 Dec 2012 | $0.110 | 03 Dec 2012 | 30 Nov -0001 | 07 Dec 2012 |
01 Nov 2012 | $0.120 | 01 Nov 2012 | 30 Nov -0001 | 07 Nov 2012 |
01 Oct 2012 | $0.120 | 01 Oct 2012 | 30 Nov -0001 | 05 Oct 2012 |
04 Sep 2012 | $0.120 | 04 Sep 2012 | 30 Nov -0001 | 10 Sep 2012 |
01 Aug 2012 | $0.120 | 01 Aug 2012 | 30 Nov -0001 | 07 Aug 2012 |
02 Jul 2012 | $0.110 | 02 Jul 2012 | 30 Nov -0001 | 09 Jul 2012 |
01 Jun 2012 | $0.110 | 01 Jun 2012 | 30 Nov -0001 | 07 Jun 2012 |
01 May 2012 | $0.120 | 01 May 2012 | 30 Nov -0001 | 07 May 2012 |
02 Apr 2012 | $0.180 | 02 Apr 2012 | 30 Nov -0001 | 09 Apr 2012 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0 | 1.500 | 0 | 0 | [0 - 0.5] |
returnOnAssetsTTM | -0.413 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -1.591 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 42.80 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 42.23 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 42.04 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0902 | -1.500 | 8.50 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -11.50 | 1.000 | -5.37 | -5.37 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.903 | 2.00 | -0.301 | -0.602 | [0 - 30] |
freeCashFlowPerShareTTM | -0.928 | 2.00 | -0.464 | -0.928 | [0 - 20] |
debtEquityRatioTTM | 0.102 | -1.500 | 9.59 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0 | 1.000 | -3.33 | -3.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0 | 1.000 | -2.00 | -2.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -1.443 | 1.000 | -9.13 | -9.13 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 0.0973 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -2.83 | 1.000 | -0.387 | 0 | [1 - 100] |
returnOnEquityTTM | -1.591 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.928 | 2.00 | -0.309 | -0.928 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.903 | 2.00 | -0.301 | -0.602 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0283 | 1.500 | -3.52 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | -1.939 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
enGene Holdings Inc.
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。